Our Mission
To demystify clinical trials and simplify participation, empowering patients with the information to make informed healthcare decisions while enabling researchers and industry partners to conduct more efficient and inclusive trials.
Passion - Our CEO's story
Why I need to do this
pRxEngage didn’t come from some business plan or market research. It came from a place of deep sadness.
When I was 11 years old, I lost my best friend Sylvester to Sickle Cell Disease. It was brutal. Back then, there wasn’t much anyone could do, and watching him go through that… it just broke me.
Sylvester was always laughing, always the life of the party. He should have had his whole life ahead of him. Seeing his family at the funeral, the pain in their eyes… I knew this was not right, but I did not yet know that I would make it my life’s work to limit that feeling where I could. I didn’t want anyone else to feel that kind of loss, that sense of helplessness.
I come from a family of doctors. My grandpa was one of the best GPs you’d ever meet. He dedicated his life to helping people, and that always inspired me. Even though I didn’t become a doctor myself, I knew I wanted to make a difference in healthcare.
So I went into research, and I’ve spent my career working to develop new treatments. I believe that new medicines can give people hope, a chance at a life they might not have otherwise had. That’s what drives me.
Our Team
With over two decades of experience in pharmaceutical and biotechnology clinical research, patient engagement, and health technology, Keith focuses on operational excellence and patient-centric research.
Before founding pRxEngage, Keith launched patientRx Ltd., a consultancy optimizing clinical trials through technology-enhanced patient engagement. He previously served as Operations and Commercial Director at Richmond Pharmacology, where he led teams to achieve significant revenue growth and global recognition for the site.
Additionally, Keith currently chairs the Fulham Research Ethics Committee (Health Research Authority) and has held advisory and committee roles including EUCROF Early Phase Working Group Chair and CCRA Executive Committee member. Keith leverages his extensive experience to commercialise technology-driven solutions that make clinical research more inclusive, efficient, and collaborative.
Prior to joining Sharecare, he held leadership roles with various private and public companies. These included Chief Technology Officer of MedCast/WebMD with a focus on Webmd.com consumer content and delivery technologies, Chief Technology Officer of PGi, where he led all global technology operations, research and development, product innovations and the integration of numerous acquired technologies.
Additionally, he has served on numerous executive boards and held advisory positions for healthcare IT, communication services companies and electronic payment processors.
David received his Bachelor of Science in Management and Information Systems from the University of Tennessee.
David brings a balance of technical expertise and board-level communication skills.
“I am excited to improve healthcare by leveraging pRxEngage to streamline the management of patient trials using the latest cloud and AI technologies, making life-enhancing and life-saving treatments more accessible to patients.”
Currently serving as the CEO of Voxco, a PE backed global leader in survey tools for researchers.
Prior to being a CEO, Daniel led product and sales organizations at public and private companies.
Daniel Graff-Radford started his entrepreneurial career while attending Emory University, where he and a partner ran an online travel booking company called African Adventures.
Ethan implemented SDLC / Agile development methodologies across a full-stack dev team, he also oversaw the process of certifying HIPAA compliance.
Prior to Network Progression, Ethan was on the production team at Mountaintop Studios, an Andreessen Horowitz backed game development studio. Besides the product management work, Ethan took their first game through the ESRB ratings process.
Before working in technology companies, he was a System Administrator at Capstone Academy seeing them move to a virtual environment during Covid.
Charlie brings a wealth of experience in building and scaling technology solutions, previously serving as the Founding CTO of In The Network. There, he architected a legal-medical case management platform, scaling the company from a three-person startup to over 500 employees and leading a global engineering team to develop NetProApp, a custom CRM utilized daily across the organization.
His career is marked by a consistent focus on building scalable systems and solving complex operational challenges.
Additionally, he has served on numerous executive boards and held advisory positions for healthcare IT, communication services companies and electronic payment processors.
David received his Bachelor of Science in Management and Information Systems from the University of Tennessee.
David brings a balance of technical expertise and board-level communication skills.
His impressive background includes pivotal senior roles in venture capital, corporate development, and commercial management, equipping him with a multifaceted perspective on business growth and innovation.
Michael is a proven expert in driving large digital transformation initiatives, with a track record of success for clients across European and US markets. His strategic counsel is further reinforced by his standing as a Fellow of the Institute of Chartered Accountants.
He has deep knowledge within healthcare services, pharma, medical devices, and digital health sectors. Elad’s current roles include as a board member for MEDX Xelerator LP, VLX Ventures, Imel Biotherapeutics Inc and senior advisor for a UK-based major investor in health-tech, to an NHS primary care provider on research strategy, and to a global pharmaceutical company on international expansion.
I’m very excited and committed to make innovative, life changing treatments more accessible for patients, and now is the time with the wealth of innovation in medicine, and enabling technologies.”
Michael is a proven expert in driving large digital transformation initiatives, with a track record of success for clients across European and US markets. His strategic counsel is further reinforced by his standing as a Fellow of the Institute of Chartered Accountants.
GET IN TOUCH
Everyone deserves a voice in shaping the future of healthcare.
